(Q39653780)

English

A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.

scientific article published on February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

multicenter clinical trial

0 references

1 reference

ChEBI release 2020-05-28

invasive fungal infections

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Fengrong Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yuhong Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ting Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jianxiang Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jianda Hu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jin Jie

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Fangping Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Shujie Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Zhixiang Shen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Li Yu

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Kang Yu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yingmin Liang

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Future Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

201-209

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Pathogenicity and drug resistance in Candida albicans and other yeast species. A review

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Amphotericin B: spectrum and resistance

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Recent advances in antifungal pharmacotherapy for invasive fungal infections

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Posaconazole: a broad-spectrum triazole antifungal

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.158

21 January 2018

Identifiers

10.2217/FMB.11.158

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324990%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39653780&oldid=1786455694"